Absent a federal committee’s recommendation, Duchenne muscular dystrophy advocates are trying to get states to adopt ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

For payers, claims for rare disease treatments used to be uncommon. Not anymore, thanks to an increasing number of new, ...

According to the latest edition of The Cancer Atlas, lower-income nations are experiencing a rise in lung, colorectal and ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, ...

The financial balancing act between providers, government programs and commercial insurers, according to Christoph Dankert, ...